Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study.
Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study. Inflamm Bowel Dis. 2007 Oct; 13(10):1250-5.